Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280864 · ClinicalTrials.gov registry record
MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS
A clinical trial, sponsored by Augusta University.
- Terminated
- Registry status
- 36
- Enrollment target
NCT01280864: Clinical Trial study, sponsored by Augusta University.
NCT01280864 is a clinical trial that was terminated before completion, run by Augusta University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01280864 was terminated before completion, sponsored by Augusta University.
- TERMINATED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Hypotheses: 1. The bidirectional signaling between the cortex, and the pelvic floor/gut is deranged in patients with IC and in IBS. Consequently, they will demonstrate hyperexcitability of the pelvic floor/brain axis as evidenced by shorter latencies and increased amplitudes for both the afferent anorectal-cortical evoked potentials and efferent cortically-induced (magnetic) anorectal motor evoked potentials. 2. Unlike patients with IC alone, patients with IBS will also demonstrate anorectal visceral hypersensitivity and anorectal sensory-motor dysfunction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-08 |
Why NCT01280864 stopped before completion
NCT01280864 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01280864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01280864 about?
NCT01280864 is a clinical study titled "MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS". Hypotheses: 1. The bidirectional signaling between the cortex, and the pelvic floor/gut is deranged in patients with IC and in IBS. Consequently, they will demonstrate hyperexcitability of the pelvic floor/brain axis as evidenced by shorter latencies and increased amplitudes for both the afferent a...
What is the current status of trial NCT01280864?
This trial is currently terminated. The enrollment target is 36 participants. The study started on 2010-03. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01280864?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia